{"hands_on_practices": [{"introduction": "Many signaling pathways are built upon the reversible modification of proteins, most commonly phosphorylation. This practice models the fundamental kinetic \"tug-of-war\" between a kinase and a phosphatase acting on a single site. By applying steady-state assumptions and mass-action kinetics, this exercise will allow you to derive how the fractional phosphorylation of a substrate is controlled not by the absolute concentration of the enzymes, but by the ratio of their catalytic activities, providing a quantitative foundation for understanding molecular switches [@problem_id:2523650].", "problem": "A bacterial response regulator protein with a single phosphorylation site cycles between an unphosphorylated form, denoted $S$, and a phosphorylated form, denoted $S_p$. A specific kinase, denoted $K$, catalyzes $S \\to S_p$, and a specific phosphatase, denoted $P$, catalyzes $S_p \\to S$. Assume a well-mixed cytosol of constant volume with no synthesis or degradation of the substrate protein on the timescale considered. Further assume that both enzymes operate under conditions where substrate concentrations are low relative to their Michaelis constants, so that the catalytic efficiency, defined as the ratio of turnover number to Michaelis constant, $k_{\\mathrm{cat}}/K_m$, is an appropriate second-order rate constant for the corresponding bimolecular step. Let the total substrate concentration be $[S]_{\\mathrm{tot}} = [S] + [S_p]$. The system is at steady state with respect to phosphorylation, meaning that the net rate of change of $[S_p]$ is zero.\n\nMeasured catalytic efficiencies and cellular concentrations are:\n- kinase catalytic efficiency $(k_{\\mathrm{cat}}/K_m)_{\\mathrm{kin}} = 2.5 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$,\n- phosphatase catalytic efficiency $(k_{\\mathrm{cat}}/K_m)_{\\mathrm{pho}} = 1.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$,\n- kinase concentration $[K] = 30\\ \\mathrm{nM}$,\n- phosphatase concentration $[P] = 12.5\\ \\mathrm{nM}$,\n- total substrate concentration $[S]_{\\mathrm{tot}} = 5\\ \\mu\\mathrm{M}$.\n\nStarting only from mass-action kinetics, the definition of catalytic efficiency $k_{\\mathrm{cat}}/K_m$ in the unsaturated regime, and the steady-state condition, derive an expression for the fractional occupancy $f$ of the phosphorylation site, defined as $f = [S_p]/[S]_{\\mathrm{tot}}$, in terms of $(k_{\\mathrm{cat}}/K_m)_{\\mathrm{kin}}$, $(k_{\\mathrm{cat}}/K_m)_{\\mathrm{pho}}$, $[K]$, and $[P]$. Then compute its value using the numbers provided.\n\nExpress the final numerical value of $f$ as a unitless decimal fraction. If rounding is needed, round to four significant figures. Do not report a percentage.", "solution": "The fundamental base is the application of mass-action kinetics to enzyme-catalyzed reactions in the unsaturated regime and the steady-state condition for an intermediate. When $[S] \\ll K_m$ for a given enzyme, the Michaelis–Menten rate law reduces to a bimolecular rate law where the second-order rate constant is $k_{\\mathrm{cat}}/K_m$. Specifically, for the kinase-catalyzed step $S \\to S_p$,\n$$\nv_{\\mathrm{kin}} = \\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{kin}} [K][S],\n$$\nand for the phosphatase-catalyzed step $S_p \\to S$,\n$$\nv_{\\mathrm{pho}} = \\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{pho}} [P][S_p].\n$$\nAt steady state with respect to phosphorylation, the net rate of change of the phosphorylated form is zero, so\n$$\n\\frac{d[S_p]}{dt} = v_{\\mathrm{kin}} - v_{\\mathrm{pho}} = 0 \\quad \\Rightarrow \\quad v_{\\mathrm{kin}} = v_{\\mathrm{pho}}.\n$$\nLet the fractional occupancy be $f = [S_p]/[S]_{\\mathrm{tot}}$, where $[S]_{\\mathrm{tot}} = [S] + [S_p]$. Then $[S_p] = f\\,[S]_{\\mathrm{tot}}$ and $[S] = (1 - f)\\,[S]_{\\mathrm{tot}}$. Substituting these into the steady-state equality gives\n$$\n\\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{kin}} [K]\\,(1 - f)\\,[S]_{\\mathrm{tot}} \\;=\\; \\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{pho}} [P]\\; f\\; [S]_{\\mathrm{tot}}.\n$$\nCanceling $[S]_{\\mathrm{tot}}$ (which is positive) yields\n$$\n\\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{kin}} [K]\\,(1 - f) \\;=\\; \\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{pho}} [P]\\; f.\n$$\nDefine the pseudo-first-order rate constants\n$$\n\\alpha \\equiv \\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{kin}} [K], \\qquad \\beta \\equiv \\left(\\frac{k_{\\mathrm{cat}}}{K_m}\\right)_{\\mathrm{pho}} [P].\n$$\nThen the equation becomes\n$$\n\\alpha (1 - f) = \\beta f \\quad \\Rightarrow \\quad \\alpha = f(\\alpha + \\beta) \\quad \\Rightarrow \\quad f = \\frac{\\alpha}{\\alpha + \\beta}.\n$$\nThis expression shows that $f$ is independent of $[S]_{\\mathrm{tot}}$ under the stated assumptions.\n\nNow compute $\\alpha$ and $\\beta$ from the given numbers, taking care with units. Convert nanomolar to molar: $30\\ \\mathrm{nM} = 30 \\times 10^{-9}\\ \\mathrm{M}$ and $12.5\\ \\mathrm{nM} = 12.5 \\times 10^{-9}\\ \\mathrm{M}$. Then\n$$\n\\alpha = \\left(2.5 \\times 10^{5}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}\\right)\\left(30 \\times 10^{-9}\\ \\mathrm{M}\\right)\n= (2.5 \\times 30)\\times 10^{5-9}\\ \\mathrm{s}^{-1}\n= 75 \\times 10^{-4}\\ \\mathrm{s}^{-1}\n= 7.5 \\times 10^{-3}\\ \\mathrm{s}^{-1},\n$$\nand\n$$\n\\beta = \\left(1.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}\\right)\\left(12.5 \\times 10^{-9}\\ \\mathrm{M}\\right)\n= (1.0 \\times 12.5)\\times 10^{6-9}\\ \\mathrm{s}^{-1}\n= 12.5 \\times 10^{-3}\\ \\mathrm{s}^{-1}.\n$$\nTherefore,\n$$\nf = \\frac{7.5 \\times 10^{-3}}{7.5 \\times 10^{-3} + 12.5 \\times 10^{-3}}\n= \\frac{7.5}{7.5 + 12.5}\n= \\frac{7.5}{20}\n= 0.375.\n$$\nThis value is exact in decimal form given the chosen numbers, so no rounding beyond what is shown is required. The result is unitless and represents the steady-state fractional occupancy of the phosphorylation site under the stated assumptions.", "answer": "$$\\boxed{0.375}$$", "id": "2523650"}, {"introduction": "While single-site modification is a useful model, many regulatory proteins possess multiple modification sites, enabling more complex signal processing. The system's behavior can change dramatically depending on whether these sites are modified in a strict sequence (ordered) or at random. This problem challenges you to model these two regimes as a birth-death process, revealing how an ordered mechanism can give rise to sharp, switch-like responses (ultrasensitivity), a critical feature for creating decisive cellular decisions [@problem_id:2523621].", "problem": "A substrate protein possesses $N \\in \\mathbb{N}$ identical phosphorylation sites. A kinase and a phosphatase act distributively and are far from saturation so that per-site phosphorylation and dephosphorylation follow first-order mass-action kinetics with effective rate constants $k [K]$ and $p [P]$, respectively, where $[K]$ and $[P]$ are fixed free enzyme concentrations. Define the dimensionless kinase-to-phosphatase bias $\\alpha \\equiv \\frac{k [K]}{p [P]} > 0$. Assume that enzyme binding and unbinding are rapid compared to catalysis so that a continuous-time Markov chain description over the coarse-grained phosphorylation level $i \\in \\{0,1,\\dots,N\\}$ is valid, with transitions only between adjacent levels.\n\nConsider two mechanistic regimes grounded in physically plausible microscopic constraints:\n\n1. Ordered sequential multisite phosphorylation: Only the next unphosphorylated site can be phosphorylated and only the most recently added phosphate can be removed (for example, due to a scaffold or conformational gating). Under this constraint, the forward transition rate from state $i$ to $i+1$ equals $a \\equiv k [K]$ for all $i \\in \\{0,\\dots,N-1\\}$, and the backward transition rate from state $i$ to $i-1$ equals $b \\equiv p [P]$ for all $i \\in \\{1,\\dots,N\\}$.\n\n2. Random-site multisite phosphorylation: Any of the $N-i$ unphosphorylated sites can be phosphorylated and any of the $i$ phosphorylated sites can be dephosphorylated. Under this constraint, the forward transition rate from $i$ to $i+1$ equals $(N-i)a$, and the backward transition rate from $i$ to $i-1$ equals $i b$.\n\nAssuming an ergodic steady state for each regime, let $f_{\\mathrm{ord}}(N,\\alpha)$ and $f_{\\mathrm{rand}}(N,\\alpha)$ denote the steady-state fractions of substrate molecules in the fully phosphorylated state $i=N$ for the ordered and random regimes, respectively.\n\nUsing only the mass-action law, conservation of probability, and steady-state detailed balance for one-dimensional birth–death processes, derive explicit closed-form expressions for $f_{\\mathrm{ord}}(N,\\alpha)$ and $f_{\\mathrm{rand}}(N,\\alpha)$, and then derive the simplified closed-form expression for the ratio\n$$\nR(N,\\alpha) \\equiv \\frac{f_{\\mathrm{ord}}(N,\\alpha)}{f_{\\mathrm{rand}}(N,\\alpha)}.\n$$\nExpress your final answer as a single analytic expression for $R(N,\\alpha)$.\n\nIn your derivation, articulate the mechanistic condition underlying each regime and explain, based on your mathematical expressions, the implication for threshold behavior at $\\alpha = 1$ (kinase and phosphatase balanced) and for temporal control as $N$ increases, without invoking any unstated empirical formulas. No numerical evaluation is required, and no rounding is needed. Express the final answer without units.", "solution": "The system is a one-dimensional birth-death process on the states $i \\in \\{0, 1, \\dots, N\\}$. Let $\\pi_i$ be the steady-state probability of being in state $i$. At steady state, the principle of detailed balance requires that the net flux between any two adjacent states is zero.\n$$\n\\pi_i k_{i \\to i+1} = \\pi_{i+1} k_{i+1 \\to i}\n$$\nThis gives a recurrence relation for the probabilities:\n$$\n\\pi_{i+1} = \\pi_i \\frac{k_{i \\to i+1}}{k_{i+1 \\to i}}\n$$\nBy applying this relation recursively, we can express any $\\pi_i$ in terms of $\\pi_0$:\n$$\n\\pi_i = \\pi_0 \\prod_{j=0}^{i-1} \\frac{k_{j \\to j+1}}{k_{j+1 \\to j}}\n$$\nThe probabilities must sum to unity due to conservation of probability: $\\sum_{i=0}^{N} \\pi_i = 1$. This allows us to solve for $\\pi_0$:\n$$\n\\pi_0 = \\left( \\sum_{i=0}^{N} \\prod_{j=0}^{i-1} \\frac{k_{j \\to j+1}}{k_{j+1 \\to j}} \\right)^{-1}\n$$\nThe fraction of fully phosphorylated protein is $f = \\pi_N$.\n\nWe first analyze the **ordered sequential regime**. The transition rates are given as $k_{i \\to i+1} = a$ and $k_{i \\to i-1} = b$. Let $\\alpha = a/b$. The ratio of rates for any transition is constant:\n$$\n\\frac{k_{j \\to j+1}}{k_{j+1 \\to j}} = \\frac{a}{b} = \\alpha\n$$\nThe product term for $\\pi_i$ becomes:\n$$\n\\prod_{j=0}^{i-1} \\alpha = \\alpha^i\n$$\nThus, the steady-state probabilities are $\\pi_i = \\pi_0 \\alpha^i$. The distribution is geometric. The normalization condition is $\\sum_{i=0}^{N} \\pi_i = \\pi_0 \\sum_{i=0}^{N} \\alpha^i = 1$. The fraction in the fully phosphorylated state, $f_{\\mathrm{ord}}(N,\\alpha)$, is $\\pi_N$:\n$$\nf_{\\mathrm{ord}}(N,\\alpha) = \\pi_N = \\frac{\\pi_0 \\alpha^N}{\\pi_0 \\sum_{i=0}^{N} \\alpha^i} = \\frac{\\alpha^N}{\\sum_{i=0}^{N} \\alpha^i}\n$$\nThe denominator is a finite geometric series, $\\sum_{i=0}^{N} \\alpha^i = \\frac{\\alpha^{N+1}-1}{\\alpha-1}$ for $\\alpha \\neq 1$. Therefore:\n$$\nf_{\\mathrm{ord}}(N,\\alpha) = \\frac{\\alpha^N (\\alpha-1)}{\\alpha^{N+1}-1}\n$$\n\nNext, we analyze the **random-site regime**. The transition rates are $k_{i \\to i+1} = (N-i)a$ and $k_{i \\to i-1} = ib$. The ratio of rates for a transition from state $j$ is:\n$$\n\\frac{k_{j \\to j+1}}{k_{j+1 \\to j}} = \\frac{(N-j)a}{(j+1)b} = \\frac{N-j}{j+1} \\alpha\n$$\nThe product term for $\\pi_i$ becomes:\n$$\n\\prod_{j=0}^{i-1} \\left( \\frac{N-j}{j+1} \\alpha \\right) = \\alpha^i \\prod_{j=0}^{i-1} \\frac{N-j}{j+1}\n$$\nThe product of rational terms is recognized as the binomial coefficient:\n$$\n\\prod_{j=0}^{i-1} \\frac{N-j}{j+1} = \\frac{N(N-1)\\cdots(N-i+1)}{1 \\cdot 2 \\cdots i} = \\frac{N!}{i!(N-i)!} = \\binom{N}{i}\n$$\nThus, the steady-state probabilities are $\\pi_i = \\pi_0 \\binom{N}{i} \\alpha^i$. The normalization condition is $\\sum_{i=0}^{N} \\pi_i = \\pi_0 \\sum_{i=0}^{N} \\binom{N}{i} \\alpha^i = 1$. The sum is given by the binomial theorem: $\\sum_{i=0}^{N} \\binom{N}{i} \\alpha^i = (1+\\alpha)^N$.\nThe fraction in the fully phosphorylated state, $f_{\\mathrm{rand}}(N,\\alpha)$, is $\\pi_N$:\n$$\nf_{\\mathrm{rand}}(N,\\alpha) = \\pi_N = \\frac{\\pi_0 \\binom{N}{N} \\alpha^N}{\\pi_0 (1+\\alpha)^N} = \\frac{\\alpha^N}{(1+\\alpha)^N} = \\left(\\frac{\\alpha}{1+\\alpha}\\right)^N\n$$\nThis is a form of the Hill-Langmuir equation, characteristic of independent sites.\n\nFinally, we compute the ratio $R(N,\\alpha)$:\n$$\nR(N,\\alpha) = \\frac{f_{\\mathrm{ord}}(N,\\alpha)}{f_{\\mathrm{rand}}(N,\\alpha)} = \\frac{\\frac{\\alpha^N}{\\sum_{i=0}^{N} \\alpha^i}}{\\frac{\\alpha^N}{(1+\\alpha)^N}} = \\frac{(1+\\alpha)^N}{\\sum_{i=0}^{N} \\alpha^i}\n$$\nTo express this as a single analytic expression without summation notation, we substitute the formula for the geometric series:\n$$\nR(N,\\alpha) = \\frac{(1+\\alpha)^N}{\\frac{\\alpha^{N+1}-1}{\\alpha-1}} = \\frac{(\\alpha-1)(1+\\alpha)^N}{\\alpha^{N+1}-1}\n$$\n\n**Interpretation:**\nThe mechanistic difference between the two regimes lies in how phosphorylation sites are accessed. The ordered regime implies a processive-like or gated mechanism where sites are modified in a strict sequence, $1 \\to 2 \\to \\dots \\to N$. The random regime implies all unoccupied sites are equally accessible for phosphorylation and all occupied sites are equally accessible for dephosphorylation, representing a scenario of independent sites.\n\nRegarding threshold behavior at $\\alpha=1$, where kinase and phosphatase activities are balanced, the fractions of fully phosphorylated protein are markedly different. For the random case, $f_{\\mathrm{rand}}(N,1) = (1/2)^N$. For the ordered case, the expression is indeterminate $0/0$, and we use L'Hôpital's rule or reason that at $\\alpha=1$, all $\\pi_i$ are equal, so $\\pi_N = f_{\\mathrm{ord}}(N,1) = 1/(N+1)$. As $N$ increases, $f_{\\mathrm{rand}}$ drops to zero much faster than $f_{\\mathrm{ord}}$. This indicates that for balanced enzymes, the random mechanism almost never produces a fully phosphorylated protein, while the ordered one maintains a non-trivial, albeit small, fraction. The response of $f_{\\mathrm{ord}}$ to changes in $\\alpha$ around $\\alpha=1$ is much steeper than for $f_{\\mathrm{rand}}$ when $N$ is large. This steep, switch-like behavior, or ultrasensitivity, is a key feature of ordered multisite modification systems.\n\nThis leads to the concept of temporal control. The ordered mechanism functions as a counter or timer. A protein molecule must undergo $N$ sequential net phosphorylation events to become fully active. This imposes a significant delay and ensures that a substantial population of fully phosphorylated protein only appears once the kinase activity is sufficiently dominant (e.g., $\\alpha$ is significantly greater than $1$) for a sustained duration. This creates a robust temporal filter. In contrast, the random mechanism lacks this memory; phosphorylation events are not sequential. It results in a broad binomial distribution of phospho-states, meaning that for any $\\alpha > 0$, there will be a heterogeneous mixture of molecules with varying degrees of phosphorylation. The ordered mechanism, by concentrating the probability distribution at the extremes (all-or-none), provides a more decisive and temporally controlled cellular switch.", "answer": "$$\n\\boxed{\\frac{(\\alpha-1)(1+\\alpha)^N}{\\alpha^{N+1}-1}}\n$$", "id": "2523621"}, {"introduction": "Post-translational modifications often serve as signals that determine a protein's fate, including its destruction. This practice connects the concepts of N-terminal processing—a key co-translational modification—to protein stability through the N-end rule pathway for proteolysis. By calculating the expected protein lifetime based on the probabilities of different processing events, you will gain a quantitative appreciation for how tuning the efficiencies of enzymes like methionine aminopeptidases and N-acetyltransferases can directly regulate the cellular proteome [@problem_id:2523688].", "problem": "In bacterial cells, N-terminal methionine excision (NME) by Methionine aminopeptidase (MetAP) is a co-translational processing event that depends on the size of the penultimate residue. In the bacterial N-end rule pathway, exposure of a bulky hydrophobic residue such as phenylalanine at the N-terminus creates a primary destabilizing residue that is recognized by the ClpS adaptor and targeted to Adenosine Triphosphate (ATP)-dependent ClpAP proteolysis with a high first-order degradation rate. N-terminal acetylation by an N-acetyltransferase (NAT), when it occurs on such an exposed residue, blocks ClpS recognition and yields a distinct, typically slower first-order degradation rate. Consider an Escherichia coli expression system producing a protein whose first two residues are methionine followed by phenylalanine. Assume the following:\n\n- Co-translational processing is complete on a timescale negligible compared to subsequent degradation, so each newly synthesized molecule is instantaneously partitioned into processing states at time $t=0$.\n- Each processing state degrades independently with first-order kinetics $dN/dt=-kN$, where $k$ is a state-specific constant.\n- If the N-terminus remains methionine (no cleavage), the degradation rate constant is $k_{\\mathrm{Met}}=1.2\\times 10^{-3}\\ \\mathrm{min}^{-1}$.\n- If methionine is cleaved and phenylalanine is exposed (no acetylation), the degradation rate constant is $k_{\\mathrm{Phe}}=1.2\\times 10^{-1}\\ \\mathrm{min}^{-1}$.\n- If methionine is cleaved and the new N-terminal phenylalanine is N-acetylated, the degradation rate constant is $k_{\\mathrm{Ac}}=2.5\\times 10^{-3}\\ \\mathrm{min}^{-1}$.\n\nTwo conditions are compared:\n\n- Condition A (baseline): Because the penultimate residue is bulky, NME occurs with probability $p_{A}=0.01$. Among the cleaved molecules, NAT-mediated N-terminal acetylation occurs with probability $a_{A}=0.10$.\n- Condition B (engineered): An engineered MetAP variant increases NME to $p_{B}=0.80$, and a co-expressed NAT acetylates the exposed N-terminus with probability $a_{B}=0.90$ among the cleaved molecules.\n\nDefine the stability metric $S$ for a newly synthesized molecule as its expected mean lifetime $E[T]$ under the above assumptions. Using only first-order kinetics and the definition of expectation, derive $S$ for each condition and compute the fold-change in stability from Condition A to Condition B, i.e., compute $S_{B}/S_{A}$. Express your final answer as a unitless decimal and round to four significant figures.", "solution": "The problem requires the calculation of the expected mean lifetime of a newly synthesized protein molecule. The population of molecules is partitioned into three distinct, non-interconverting subpopulations at $t=0$, each with its own first-order degradation kinetics. The overall expected lifetime is determined by the law of total expectation, which states that the expectation of a random variable is the weighted average of the conditional expectations over a partition of the sample space.\n\nLet $T$ be the random variable representing the lifetime of a molecule. The stability metric is $S = E[T]$. The three states are: Met-retained (Met), Phe-exposed (Phe), and Ac-Phe (Ac).\n$$S = E[T] = P(\\mathrm{Met}) E[T|\\mathrm{Met}] + P(\\mathrm{Phe}) E[T|\\mathrm{Phe}] + P(\\mathrm{Ac}) E[T|\\mathrm{Ac}]$$\nThe conditional expectation $E[T|\\mathrm{State}]$ is the mean lifetime for a molecule in that specific state. For a process governed by first-order kinetics, $\\frac{dN}{dt} = -kN$, the number of molecules remaining at time $t$ is $N(t) = N_0 \\exp(-kt)$. The lifetime of any given molecule follows an exponential probability distribution with probability density function $f(t) = k \\exp(-kt)$. The mean lifetime, $\\tau$, is the expectation of this distribution:\n$$\\tau = E[T] = \\int_{0}^{\\infty} t \\cdot f(t) dt = \\int_{0}^{\\infty} tk \\exp(-kt) dt$$\nUsing integration by parts, it is a standard result that this integral evaluates to:\n$$\\tau = \\frac{1}{k}$$\nThus, the mean lifetime for each state is the reciprocal of its degradation rate constant:\n$\\tau_{\\mathrm{Met}} = \\frac{1}{k_{\\mathrm{Met}}}$, $\\tau_{\\mathrm{Phe}} = \\frac{1}{k_{\\mathrm{Phe}}}$, and $\\tau_{\\mathrm{Ac}} = \\frac{1}{k_{\\mathrm{Ac}}}$.\n\nNext, we define the probabilities of a molecule being in each state, in terms of the given parameters $p$ (probability of NME) and $a$ (probability of acetylation, given NME).\n- The probability of the N-terminal methionine being retained is the probability that NME does not occur:\n$$P(\\mathrm{Met}) = 1 - p$$\n- The probability of having an exposed N-terminal phenylalanine is the probability that NME occurs AND acetylation does not occur:\n$$P(\\mathrm{Phe}) = p \\cdot (1 - a)$$\n- The probability of having an N-acetylated N-terminal phenylalanine is the probability that NME occurs AND acetylation occurs:\n$$P(\\mathrm{Ac}) = p \\cdot a$$\nNote that $P(\\mathrm{Met}) + P(\\mathrm{Phe}) + P(\\mathrm{Ac}) = (1 - p) + p(1 - a) + pa = 1 - p + p - pa + pa = 1$, as required.\n\nSubstituting these probabilities and the expressions for mean lifetime into the equation for $S$, we obtain a general formula for stability:\n$$S(p, a) = (1 - p)\\frac{1}{k_{\\mathrm{Met}}} + p(1 - a)\\frac{1}{k_{\\mathrm{Phe}}} + pa\\frac{1}{k_{\\mathrm{Ac}}}$$\nWe now apply this formula to Condition A and Condition B.\n\nFor Condition A: $p_{A} = 0.01$ and $a_{A} = 0.10$.\nThe probabilities for each state are:\n$P_{A}(\\mathrm{Met}) = 1 - 0.01 = 0.99$\n$P_{A}(\\mathrm{Phe}) = 0.01 \\cdot (1 - 0.10) = 0.01 \\cdot 0.90 = 0.009$\n$P_{A}(\\mathrm{Ac}) = 0.01 \\cdot 0.10 = 0.001$\nThe stability $S_A$ is:\n$$S_{A} = \\frac{0.99}{k_{\\mathrm{Met}}} + \\frac{0.009}{k_{\\mathrm{Phe}}} + \\frac{0.001}{k_{\\mathrm{Ac}}}$$\nSubstituting the given rate constants:\n$$S_{A} = \\frac{0.99}{1.2 \\times 10^{-3}} + \\frac{0.009}{1.2 \\times 10^{-1}} + \\frac{0.001}{2.5 \\times 10^{-3}}$$\n$$S_{A} = 825 + 0.075 + 0.4 = 825.475\\ \\mathrm{min}$$\n\nFor Condition B: $p_{B} = 0.80$ and $a_{B} = 0.90$.\nThe probabilities for each state are:\n$P_{B}(\\mathrm{Met}) = 1 - 0.80 = 0.20$\n$P_{B}(\\mathrm{Phe}) = 0.80 \\cdot (1 - 0.90) = 0.80 \\cdot 0.10 = 0.08$\n$P_{B}(\\mathrm{Ac}) = 0.80 \\cdot 0.90 = 0.72$\nThe stability $S_B$ is:\n$$S_{B} = \\frac{0.20}{k_{\\mathrm{Met}}} + \\frac{0.08}{k_{\\mathrm{Phe}}} + \\frac{0.72}{k_{\\mathrm{Ac}}}$$\nSubstituting the given rate constants:\n$$S_{B} = \\frac{0.20}{1.2 \\times 10^{-3}} + \\frac{0.08}{1.2 \\times 10^{-1}} + \\frac{0.72}{2.5 \\times 10^{-3}}$$\n$$S_{B} = \\frac{200}{1.2} + \\frac{0.8}{1.2} + \\frac{720}{2.5} = \\frac{500}{3} + \\frac{2}{3} + 288$$\n$$S_{B} = \\frac{502}{3} + 288 = 167.333... + 288 = 455.333...\\ \\mathrm{min}$$\n\nFinally, we compute the required fold-change, $S_{B} / S_{A}$:\n$$\\frac{S_{B}}{S_{A}} = \\frac{455.333...}{825.475} \\approx 0.551596...$$\nRounding this result to four significant figures, as required by the problem statement, gives $0.5516$.\nThe engineering of the system, despite increasing the probability of a stabilizing modification (acetylation) among cleaved products, results in a net decrease in overall protein stability. This is because the high probability of NME in Condition B shifts the population away from the extremely stable Met-retained state which dominates in Condition A.", "answer": "$$\\boxed{0.5516}$$", "id": "2523688"}]}